FOXO3 and hepatocellular carcinoma: We found that overexpression of FOXO3 significantly sensitized the m6A‐mediated resistant HCC cells to sorafenib treatment either by reducing their IC50 values (Fig 5I and J) or by using cell survival assays (Fig 5K and L).